Ptc Therapeutics (PTCT) Revenue Growth (5y) (2017 - 2026)
Ptc Therapeutics (PTCT) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.24% |
| Dec 31, 2025 | 8.95% |
| Sep 30, 2025 | 12.25% |
| Jun 30, 2025 | 18.91% |
| Mar 31, 2025 | 76.71% |
| Dec 31, 2024 | 21.23% |
| Sep 30, 2024 | 22.49% |
| Mar 31, 2024 | 31.69% |
| Dec 31, 2023 | 29.04% |
| Sep 30, 2023 | 29.96% |
| Jun 30, 2023 | 226.87% |
| Mar 31, 2023 | 31.53% |
| Dec 31, 2022 | 23.64% |
| Sep 30, 2022 | 39.04% |
| Jun 30, 2022 | 28.15% |
| Mar 31, 2022 | 41.26% |
| Dec 31, 2021 | 370.06% |
| Sep 30, 2021 | 169.66% |
| Jun 30, 2021 | 258.88% |
| Mar 31, 2021 | 44.26% |